137 related articles for article (PubMed ID: 8377444)
21. Pelvis and extremity osteosarcoma with similar tumor volume have an equivalent survival.
Song WS; Cho WH; Jeon DG; Kong CB; Kim MS; Lee JA; Eid AS; Kim JD; Lee SY
J Surg Oncol; 2010 Jun; 101(7):611-7. PubMed ID: 20461769
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors among 130 patients with osteosarcoma.
Pochanugool L; Subhadharaphandou T; Dhanachai M; Hathirat P; Sangthawan D; Pirabul R; Onsanit S; Pornpipatpong N
Clin Orthop Relat Res; 1997 Dec; (345):206-14. PubMed ID: 9418642
[TBL] [Abstract][Full Text] [Related]
23. [Adjuvant chemotherapy of osteosarcoma].
Yamawaki S; Isu K; Ubayama Y; Takeda N; Yagi T; Usui M; Isii S
Gan To Kagaku Ryoho; 1990 Feb; 17(2):180-8. PubMed ID: 2301948
[TBL] [Abstract][Full Text] [Related]
24. Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma.
Lee JA; Kim MS; Kim DH; Lim JS; Yoo JY; Koh JS; Lee SY; Jeon DG; Park KD
Pediatr Blood Cancer; 2008 Feb; 50(2):195-200. PubMed ID: 18061933
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of extremity osteosarcoma in patients aged 40-60 years: a cohort/case controlled study at a single institute.
Song WS; Kong CB; Jeon DG; Cho WH; Kim MS; Lee JA; Yoo JY; Kim JD; Lee SY
Eur J Surg Oncol; 2010 May; 36(5):483-8. PubMed ID: 20363585
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F
Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184
[TBL] [Abstract][Full Text] [Related]
27. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
[TBL] [Abstract][Full Text] [Related]
28. Growth patterns of osteosarcoma predict patient survival.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
Arch Orthop Trauma Surg; 2009 Sep; 129(9):1189-96. PubMed ID: 18682966
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy of osteosarcoma].
Winkler K; Bieling P; Bielack S
Z Orthop Ihre Grenzgeb; 1992; 130(4):285-9. PubMed ID: 1413973
[TBL] [Abstract][Full Text] [Related]
30. Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry.
Winkler K; Bieling P; Bielack S; Delling G; Dose C; Jürgens H; Kotz R; Ritter J; Salzer-Kuntschik M
Clin Orthop Relat Res; 1991 Sep; (270):79-86. PubMed ID: 1715820
[TBL] [Abstract][Full Text] [Related]
31. [Neoadjuvant chemotherapy for osteosarcoma].
Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
[TBL] [Abstract][Full Text] [Related]
32. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
Hawkins DS; Arndt CA
Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
[TBL] [Abstract][Full Text] [Related]
33. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.
Jeon DG; Kong CB; Cho WH; Song WS; Cho SH; Choi SW; Lee SY
J Surg Oncol; 2014 Mar; 109(3):275-9. PubMed ID: 24243222
[TBL] [Abstract][Full Text] [Related]
34. A new relative tumor sizing method in epi-metaphyseal osteosarcoma.
Kim SH; Shin KH; Park EH; Cho YJ; Park BK; Suh JS; Yang WI
BMC Cancer; 2015 Apr; 15():284. PubMed ID: 25885468
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of prognostic factors in rhabdomyosarcoma. Preliminary univariate and multivariate results of the Cooperative Soft Tissue Sarcoma Study (CWS-81)].
Suder J; Stienen U; Kaatsch P; Harms D; Schmidt D; Spaar HJ; Treuner J
Klin Padiatr; 1986; 198(3):218-23. PubMed ID: 3523027
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the prognostic value of assessing tumor diameter versus tumor volume at diagnosis or in response to initial chemotherapy in rhabdomyosarcoma.
Ferrari A; Miceli R; Meazza C; Casanova M; Favini F; Morosi C; Trecate G; Marchianò A; Luksch R; Cefalo G; Terenziani M; Spreafico F; Polastri D; Podda M; Catania S; Schiavello E; Giannatempo P; Gandola L; Massimino M; Mariani L
J Clin Oncol; 2010 Mar; 28(8):1322-8. PubMed ID: 20124176
[TBL] [Abstract][Full Text] [Related]
37. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
Chen Y; Wang CM; Shi YQ; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
[TBL] [Abstract][Full Text] [Related]
38. [Nonmetastatic osteosarcoma of the limbs treated with neoadjuvant chemotherapy: correlation of tumor volume evaluated by CT and prognosis].
Moio A; Ferrari S; Iantorno D; Monti C; Bacci G
Minerva Med; 1994 Dec; 85(12):615-23. PubMed ID: 7854554
[TBL] [Abstract][Full Text] [Related]
39. Plasma proteome predicts chemotherapy response in osteosarcoma patients.
Li Y; Dang TA; Shen J; Hicks J; Chintagumpala M; Lau CC; Man TK
Oncol Rep; 2011 Feb; 25(2):303-14. PubMed ID: 21165584
[TBL] [Abstract][Full Text] [Related]
40. Osteosarcoma developed in the period of maximal growth rate have inferior prognosis.
Lee JA; Kim MS; Kim DH; Lim JS; Park KD; Song WS; Lee SY; Jeon DG
J Pediatr Hematol Oncol; 2008 Jun; 30(6):419-24. PubMed ID: 18525457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
